Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle

Intramammary (IMM) ceftiofur treatment is commonly used in dairy farms to prevent mastitis, though its impact on the cattle gut microbiome and selection of antibiotic-resistant bacteria has not been elucidated. Herein, we enrolled 40 healthy dairy cows after lactation: 20 were treated with IMM ceftiofur (Spectramast®DC) and a non-antibiotic internal teat sealant (bismuth subnitrate) and 20 (controls) received only bismuth subnitrate. Fecal samples were collected before (day −1) and after treatment (weeks 1, 2, 3, 5, 7, and 9) for bacterial quantification and metagenomic next-generation sequencing. Overall, 90% and 24% of the 278 samples had Gram-negative bacteria with resistance to ampicillin and ceftiofur, respectively. Most of the cows treated with ceftiofur did not have an increase in the number of resistant bacteria; however, a subset (25%) shed higher levels of ceftiofur-resistant bacteria for up to 2 weeks post-treatment. At week 5, the antibiotic-treated cows had lower microbiome abundance and richness, whereas a greater abundance of genes encoding extended-spectrum β-lactamases (ESBLs), CfxA, ACI-1, and CMY, was observed at weeks 1, 5 and 9. Moreover, the contig and network analyses detected associations between β-lactam resistance genes and phages, mobile genetic elements, and specific genera. Commensal bacterial populations belonging to Bacteroidetes most often possessed ESBL genes followed by members of Enterobacteriaceae. This study highlights variable, persistent effects of IMM ceftiofur treatment on the gut microbiome and resistome in dairy cattle. Antibiotic-treated cattle had an increased abundance of specific taxa and genes encoding ESBL production that persisted for 9 weeks, while fecal shedding of ESBL-producing Enterobacteriaceae varied across animals. Together, these findings highlight the need for additional studies that identify factors linked to shedding levels and the dissemination and persistence of resistance determinants on dairy farms in different geographic locations.

[1]  G. Suen,et al.  Incidence and Treatments of Bovine Mastitis and Other Diseases on 37 Dairy Farms in Wisconsin , 2022, Pathogens.

[2]  Dhwani K. Desai,et al.  Microbiome differential abundance methods produce different results across 38 datasets , 2022, Nature Communications.

[3]  Dhwani K. Desai,et al.  Microbiome differential abundance methods produce different results across 38 datasets , 2022, Nature Communications.

[4]  Alan D. Lopez,et al.  Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis , 2022, The Lancet.

[5]  A. Keller,et al.  PLSDB: advancing a comprehensive database of bacterial plasmids , 2021, Nucleic Acids Res..

[6]  Liqing Zhang,et al.  mobileOG-db: a Manually Curated Database of Protein Families Mediating the Life Cycle of Bacterial Mobile Genetic Elements , 2021, bioRxiv.

[7]  H. Drost,et al.  Sensitive protein alignments at tree-of-life scale using DIAMOND , 2021, Nature Methods.

[8]  S. Aly,et al.  Effect of Antimicrobial Treatment on the Dynamics of Ceftiofur Resistance in Enterobacteriaceae from Adult California Dairy Cows , 2021, Microorganisms.

[9]  G. Suen,et al.  Quantification of antimicrobial usage in adult cows and preweaned calves on 40 large Wisconsin dairy farms using dose-based and mass-based metrics. , 2021, Journal of dairy science.

[10]  Timothy L. Tickle,et al.  Multivariable association discovery in population-scale meta-omics studies , 2021, bioRxiv.

[11]  S. Peddada,et al.  Analysis of compositions of microbiomes with bias correction , 2020, Nature Communications.

[12]  Antibiotic resistance threats in the United States, 2019 , 2019 .

[13]  Geoffrey L. Winsor,et al.  CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database , 2019, Nucleic Acids Res..

[14]  S. Kathariou,et al.  Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers , 2019, PloS one.

[15]  Bas E. Dutilh,et al.  Robust taxonomic classification of uncharted microbial sequences and bins with CAT and BAT , 2019, Genome Biology.

[16]  Jinxin Liu,et al.  Bifidobacterial Dominance of the Gut in Early Life and Acquisition of Antimicrobial Resistance , 2018, mSphere.

[17]  Ole Lund,et al.  Rapid and precise alignment of raw reads against redundant databases with KMA , 2018, BMC Bioinformatics.

[18]  Chris M Rands,et al.  ACI‐1 beta‐lactamase is widespread across human gut microbiomes in Negativicutes due to transposons harboured by tailed prophages , 2018, Environmental microbiology.

[19]  G. Van Domselaar,et al.  Impact of sequencing depth on the characterization of the microbiome and resistome , 2018, Scientific Reports.

[20]  G. Oikonomou,et al.  Milk microbiome and bacterial load following dry cow therapy without antibiotics in dairy cows with healthy mammary gland , 2017, Scientific Reports.

[21]  Y. Schukken,et al.  Normal milk microbiome is reestablished following experimental infection with Escherichia coli independent of intramammary antibiotic treatment with a third-generation cephalosporin in bovines , 2017, Microbiome.

[22]  P. Pevzner,et al.  metaSPAdes: a new versatile metagenomic assembler. , 2017, Genome research.

[23]  Ynte H. Schukken,et al.  Longitudinal metagenomic profiling of bovine milk to assess the impact of intramammary treatment using a third-generation cephalosporin , 2016, Scientific Reports.

[24]  Alexey A. Gurevich,et al.  MetaQUAST: evaluation of metagenome assemblies , 2016, Bioinform..

[25]  Katherine S Pollard,et al.  Average genome size estimation improves comparative metagenomics and sheds light on the functional ecology of the human microbiome , 2015, Genome Biology.

[26]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[27]  B. Norby,et al.  Effects of Ceftiofur and Chlortetracycline Treatment Strategies on Antimicrobial Susceptibility and on tet(A), tet(B), and bla CMY-2 Resistance Genes among E. coli Isolated from the Feces of Feedlot Cattle , 2013, PloS one.

[28]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[29]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[30]  R. Singer,et al.  Quantitative measurement of blaCMY-2 in a longitudinal observational study of dairy cattle treated with ceftiofur. , 2012, Foodborne pathogens and disease.

[31]  Y. Gröhn,et al.  Mathematical Model of Plasmid-Mediated Resistance to Ceftiofur in Commensal Enteric Escherichia coli of Cattle , 2012, PloS one.

[32]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[33]  Clsi.  Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement , 2010 .

[34]  Miriam L. Land,et al.  Trace: Tennessee Research and Creative Exchange Prodigal: Prokaryotic Gene Recognition and Translation Initiation Site Identification Recommended Citation Prodigal: Prokaryotic Gene Recognition and Translation Initiation Site Identification , 2022 .

[35]  B. Norby,et al.  Quantification of the bla(CMY-2) in feces from beef feedlot cattle administered three different doses of ceftiofur in a longitudinal controlled field trial. , 2009, Foodborne pathogens and disease.

[36]  Mathieu Bastian,et al.  Gephi: An Open Source Software for Exploring and Manipulating Networks , 2009, ICWSM.

[37]  J. Chapman,et al.  The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome , 2008, Proceedings of the National Academy of Sciences.

[38]  R. Singer,et al.  Effects of Therapeutic Ceftiofur Administration to Dairy Cattle on Escherichia coli Dynamics in the Intestinal Tract , 2008, Applied and Environmental Microbiology.

[39]  J. Mainardi,et al.  Campylobacter bacteremia: clinical features and factors associated with fatal outcome. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  G. Pugliese,et al.  Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.

[41]  Jun Yu,et al.  VFDB: a reference database for bacterial virulence factors , 2004, Nucleic Acids Res..

[42]  C. Smith,et al.  Genetic and biochemical analysis of a novel Ambler class A beta-lactamase responsible for cefoxitin resistance in Bacteroides species , 1993, Antimicrobial Agents and Chemotherapy.